Variation in growth and diterpene lactones among field-cultivated Andrographis paniculata

S. Prathanturarug,N. Soonthornchareonnon,W. Chuakul,P. Saralamp

DOI: https://doi.org/10.1007/s11418-006-0115-6

IF: 3.1921

2007-01-12

Journal of Natural Medicines

Abstract:

What problem does this paper attempt to address?

H 2 O 2 Self-Supplying and GSH-Depleting Nanoplatform for Chemodynamic Therapy Synergetic Photothermal/Chemotherapy

Zhimei Xiao,Wenbao Zuo,Luping Chen,Liang Wu,Nian Liu,Jinxue Liu,Quanyi Jin,Yilin Zhao,Xuan Zhu

DOI: https://doi.org/10.1021/acsami.1c10341

2021-09-09

Abstract:Chemodynamic therapy (CDT) that utilizes Fenton-type reactions to convert endogenous hydrogen peroxide (H2O2) into hydroxyl radicals (•OH) is a promising strategy in anticancer treatment, but the overexpression of glutathione (GSH) and limited endogenous H2O2 make the efficiency of CDT unsatisfactory. Here, an intelligent nanoplatform CuO2@mPDA/DOX-HA (CPPDH), which induced the depletion of GSH and the self-supply of H2O2, was proposed. When CPPDH entered tumor cells through the targeting effect of hyaluronic acid (HA), a release of Cu2+ and produced H2O2 were triggered by the acidic environment of lysosomes. Then, the Cu2+ was reduced by GSH to Cu+, and the Cu+ catalyzed H2O2 to produce •OH. The generation of •OH could be distinctly enhanced by the GSH depletion and H2O2 self-sufficiency. Besides, an outstanding photothermal therapy (PTT) effect could be stimulated by NIR irradiation on mesoporous polydopamine (mPDA). Meanwhile, mPDA was an excellent photoacoustic reagent, which could monitor the delivery of nanocomposite materials through photoacoustic (PA) imaging. Moreover, the successful delivery of doxorubicin (DOX) realized the integration of chemotherapy, PTT, and CDT. This strategy could solve the problem of insufficient CDT efficacy caused by the limited H2O2 and overexpression of GSH. This multifunctional nanoplatform may open a broad path for self-boosting CDT and synergistic therapy.The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acsami.1c10341.Materials and experimental details, additional characterizations, flow cytometry analysis, hemolysis test in vitro, H&E staining of major organs, and hematology analysis of mice at the end of treatment (PDF)This article has not yet been cited by other publications.

materials science, multidisciplinary,nanoscience & nanotechnology
Photoperiodic induced melatonin regulates immunity and expression pattern of melatonin receptor MT1 in spleen and bone marrow mononuclear cells of male golden hamster.

D. Vishwas,C. Haldar

DOI: https://doi.org/10.1016/j.jphotobiol.2013.08.018

2013-11-05

Abstract:
Tumor-targeting polymer nanohybrids with amplified ROS generation for combined photodynamic and chemodynamic therapy

Xiaodan Chen,Danling Cheng,Ningyue Yu,Jian Feng,Jingchao Li,Lin Lin

DOI: https://doi.org/10.1039/d3tb02341a

IF: 7.571

2024-01-10

Journal of Materials Chemistry B

Abstract:Reactive oxygen species (ROS) generating strategies have been widely adopted for cancer therapy, but therapeutic efficacies are often low due to the complicated tumor microenvironment. In this study, we present the development of tumor-targeting polymer nanohybrids that amplify ROS generation by combining photodynamic therapy (PDT) and chemodynamic therapy (CDT) for cancer treatment. Such polymer nanohybrids contained three main components: a semiconducting polymer (SP) that acted as the photosensitizer for PDT, manganese dioxide (MnO 2 ) that acted as the catalyst for CDT, and transferrin that mediated tumor targeting via binding to transferrin receptors overexpressed on the surface of tumor cells. The formed nanohybrids (TSM) showed obviously enhanced accumulation efficacy in tumor sites because of their targeting ability. In tumor sites, TSM produced singlet oxygen ( 1 O 2 ) under near-infrared (NIR) laser irradiation and a hydroxyl radical ( ̇OH) via reacting with hydrogen peroxide (H 2 O 2 ), which resulted in amplified generation of ROS to achieve PDT/CDT combinational therapy. The growth of subcutaneous 4T1 tumors was remarkably inhibited via TSM-mediated treatment. In addition, this therapeutic efficacy could suppress tumor metastasis in the liver and lungs. This study presents a targeting hybrid nanoplatform to combine different ROS generating strategies for effective cancer therapy.

materials science, biomaterials
Open-Source and Reduced-Expenditure Nanosystem with ROS Self-Amplification and Glutathione Depletion for Simultaneous Augmented Chemodynamic/Photodynamic Therapy

Miaomiao Chen,Shuju Zhao,Jialong Zhu,Erting Feng,Fangyuan Lv,Wenlong Chen,Shibo Lv,Yingnan Wu,Xiaojun Peng,Fengling Song

DOI: https://doi.org/10.1021/acsami.2c01782

IF: 9.5

2022-05-02

ACS Applied Materials & Interfaces

Abstract:Reactive oxygen species (ROS)-induced cell apoptosis has emerged as an efficient strategy for cancer therapy. However, tumor hypoxia and insufficient amounts of endogenous hydrogen peroxide (H2O2) in the tumor microenvironment are currently the main limitations of photodynamic therapy (PDT) and chemodynamic therapy (CDT). Moreover, the glutathione (GSH) scavenging effect on ROS further hinders the efficiency of ROS-mediated therapy. Here, a CaO2-based nanosystem (named as CF@CO@HC) with ROS self-amplification and GSH-depletion abilities was developed by a bottom-up approach. This hybrid nanoparticle consisted of a photosensitizer-doped calcium peroxide (CaO2) core (CaO2-FM), a hybrid organosilica framework (Cu-ONS) incorporated with Fenton reagents (Cu2+) and tetrasulfide groups, and a local hydrophobic cage (HC) shell. The photosensitizer was fluorescein derivative 4-FM with a thermally activated delayed fluorescence (TADF) property. The HC shell was built to protect the CaO2 and the photosensitizer from being attacked by water. Upon being internalized into cancer cells, the nanosystem was decomposed through the reduction reactions of Cu2+ and the tetrasulfide bond-doped silica shell by GSH, thus releasing Cu+ for Cu+-mediated CDT. Meanwhile, the exposed CaO2-FM can react with H2O to liberate photosensitizer 4-FM and generate H2O2 and O2 to overcome barriers in CDT and PDT. Thus, our study provided an open-source and reduced-expenditure strategy via GSH depletion and ROS self-amplification behaviors for ROS generation and significantly achieved an improved synergistic PDT/CDT for cancers.

materials science, multidisciplinary,nanoscience & nanotechnology
Glutathione/pH-responsive copper-based nanoplatform for amplified chemodynamic therapy through synergistic cycling regeneration of reactive oxygen species and dual glutathione depletion

Sihan Jia,Sunkui Ke,Li Tu,Shengqiang Chen,Bingkun Luo,Yeqi Xiong,Yang Li,Peiyuan Wang,Shefang Ye

DOI: https://doi.org/10.1016/j.jcis.2023.08.043

IF: 9.9

2023-08-19

Journal of Colloid and Interface Science

Abstract:The rapid scavenging of reactive oxygen species (ROS) by glutathione (GSH) and insufficient endogenous hydrogen peroxide (H 2 O 2 ) in tumor cells are the major factors greatly restricting the efficacy of chemodynamic therapy (CDT). Herein, we developed a tumor microenvironment (TME)-responsive Cu-based metal-mesoporous organosilica nanoplatform integrating vitamin k3 (VK3), which could deplete GSH and specifically regenerate H 2 O 2 for amplified CDT of cancer. Once the CuO@MON-PEG/VK3 nanoparticles entered into the tumor cells through enhanced permeability and retention (EPR) effect, the organosilicon shell and CuO core would be successively degraded upon the triggering of GSH and endo/lysosomal acidity. Subsequently, the enriched tetrasulfide bridges and released Cu 2+ could consume GSH substantially, thus triggering Fenton-like reaction for CDT. Furthermore, the released VK3 could be catalyzed by the highly expressed quinone oxidoreductase-1 (NQO1) inside tumor cells to generate sufficient H 2 O 2 through a "reversible" redox cycle, which in turn promoted Cu + -mediated Fenton-like reaction. Both in vitro and in vivo studies demonstrated that this nanoplatform could achieve synergistic CDT against tumor through synergistic cycling regeneration of ROS and dual GSH exhaustion with excellent biosafety. Our finding highlight the promising potential of CuO@MON-PEG/VK3 nanoplatform with multiple oxidative stress amplification for highly efficient tumor therapy.

chemistry, physical
Self-Supply Oxygen ROS Reactor via Fenton-like Reaction and Modulating Glutathione for Amplified Cancer Therapy Effect

Huanli Zhang,Wei Ma,Zhiqiang Wang,Xiaodan Wu,Hui Zhang,Wen Fang,Rui Yan,Yingxue Jin

DOI: https://doi.org/10.3390/nano12142509

IF: 5.3

2022-07-21

Nanomaterials

Abstract:Reactive oxygen species (ROS) are highly reactive oxidant molecules that can kill cancer cells through irreversible damage to biomacromolecules. ROS-mediated cancer therapies, such as chemodynamic (CDT) and photodynamic therapy (PDT), are often limited by the hypoxia tumor microenvironment (TME) with high glutathione (GSH) level. This paper reported the preparation, characterization, in vitro and in vivo antitumor bioactivity of a meso-tetra(4-carboxyphenyl)porphine (TCPP)-based therapeutic nanoplatform (CMMFTP) to overcome the limitations of TME. Using Cu2+ as the central ion and TCPP as the ligand, the 2D metal-organic framework Cu-TCPP was synthesized by the solvothermal method, then CMMFTP was prepared by modifying MnO2, folic acid (FA), triphenylphosphine (TPP), and poly (allylamine hydrochloride) (PAH) on the surface of Cu-TCPP MOFs. CMMFTP was designed as a self-oxygenating ROS nanoreactor based on the PDT process of TCPP MOFs and the CDT process by Cu(II) and MnO2 components (mainly through Fenton-like reaction). The in vitro assay suggested CMMFTP caused a 96% lethality rate against Hela cells (MTT analysis) in specific response to TME stimulation. Moreover, the Cu(II) and MnO2 in CMMFTP efficiently depleted the glutathione (80%) in tumor cells and consequently amplified ROS levels to improve CDT/PDT effects. The FA-induced tumor targeting and TPP-induced mitochondria targeting further enhanced the antitumor activity. Therefore, the nanoreactor based on dual targeting and self-oxygenation-enhanced ROS mechanism provided a new strategy for cancer therapy.

materials science, multidisciplinary,physics, applied,nanoscience & nanotechnology,chemistry
Hydrogen peroxide self-sufficient and glutathione-depleted nanoplatform for boosting chemodynamic therapy synergetic phototherapy

Huijun Zhang,Renlu Han,Pengxin Song,Xiangjun Wei,Yafei Hou,Jiancheng Yu,Keqi Tang

DOI: https://doi.org/10.1016/j.jcis.2022.08.156

IF: 9.9

2022-08-31

Journal of Colloid and Interface Science

Abstract:Chemodynamic therapy (CDT), which suppresses tumors via the conversion of endogenous hydrogen peroxide (H 2 O 2 ) to highly toxic hydroxyl radicals (•OH), is deemed as a cutting-edge antitumor strategy. However, the insufficient endogenous H 2 O 2 and up-regulated antioxidant glutathione (GSH) in the tumor microenvironment (TME) greatly impede the therapeutic effect of CDT. Herein, a versatile nanoplatform MgO 2 @SnFe 2 O 4 @PEG (MSnFeP) is elaborately fabricated for boosting CDT synergetic phototherapy. In the TME, the activation of MSnFeP contributes to in situ supply of H 2 O 2 , generation of •OH and consumption of GSH for boosted CDT. Furthermore, photothermal therapy (PTT) and photodynamic therapy (PDT) are simultaneously stimulated by near-infrared (NIR) light exposure on MSnFeP to increase the toxic free radical yield. This strategy not only amplifies the CDT efficacy hindered by H 2 O 2 deficiency and GSH overexpression, but also further enhances the therapeutic effect with the combination of phototherapy.

chemistry, physical
A hollow Co3-xCuxS4 with glutathione depleting and photothermal properties for synergistic dual-enhanced chemodynamic/photothermal cancer therapy

Ying Jiang,Hao Lu,Xiangyang Yuan,Lingli Lei,Yongcan Li,Wei Sun,Jing Liu,Daniel Scherman,Yingshuai Liu,YuanYuan Zhang

DOI: https://doi.org/10.1039/d2tb01590k

IF: 7.571

2022-09-10

Journal of Materials Chemistry B

Abstract:Chemodynamic therapy has become an emerging cancer treatment strategy, in which tumor cells are killed through toxic reactive oxygen species (ROS) produced by the Fenton reaction, especially hydroxyl radical (•OH). Nevertheless, low ROS generation efficiency and ROS depletion by cellular antioxidant systems are still the main obstacles in chemodynamic therapy. In the present work, we propose a dually enhanced chemodynamic therapy obtained by inhibiting •OH consumption and promoting •OH production, which is based on the administration of hollow nanoparticles composed of a bimetallic sulfide Co3-xCuxS4 functionalized by polyethylene glycol. These bimetallic nanoparticles display glutathione depleting and photothermal properties. The nanoparticles are gradually degraded in cellular media, and potentially in tumor microenvironment, which results in Co2+ and Cu2+ release. The released Co2+ triggers a Fenton-like reaction that turn endogenous hydrogen peroxide to highly toxic •OH. In the cellular environment, Cu2+ ions are reduced into Cu+ by endogenous GSH, which decreases the intracellular antioxidant capacity and additionally up-regulates •OH production via Cu+-induced Fenton-like reaction. Moreover, under near-infrared light irradiation, the bimetallic nanoparticles display a photothermal conversion efficacy of 46.7%, which not only improves chemodynamic therapy via boosting Fenton-like reaction but results in photothermal therapy through hyperthermia. Both in vitro cancer cell killing and in vivo tumor ablation experiments show that the bimetallic nanoparticles display outstanding therapeutic efficacy and negligible systemic toxicity, indicating their anticancer potential.

materials science, biomaterials
A Photo‐Activated Continuous Reactive Oxygen Species Nanoamplifier for Dual‐Dynamic Cascade Cancer Therapy

Xu Zhang,Xinlu Zhang,Haizhen Guo,Shitian Jia,Yong Li,Suixin Xing,Jin Chang,Sheng Wang

DOI: https://doi.org/10.1002/adhm.202301469

IF: 10

2023-08-14

Advanced Healthcare Materials

Abstract:The special redox homeostasis of tumor cells makes reactive oxygen species (ROS)‐based approaches a promising cancer therapeutic strategy. Among these approaches, photodynamic therapy (PDT) is the most widely studied ROS‐based treatment due to its ability to achieve targeted therapy by local light irradiation. However, achieving efficient and continuous ROS generation without prolonged laser exposure is still challenging. In this work, we propose a photo‐activated continuous ROS nanoamplifier for photodynamic‐chemodynamic cascade therapy. Upon local laser irradiation, the nanoamplifier can continuously amplify cellular oxidative stress through positive feedback loop of "light‐triggered ROS generation, ROS‐responsive prodrug activation and Fenton reaction‐meadiated ROS cyclic regenerative amplification", avoiding tissue damage caused by excessive laser exposure. This strategy provides a potential pathway to overcome the limitations of ROS‐based therapeutic approaches. This article is protected by copyright. All rights reserved

nanoscience & nanotechnology,engineering, biomedical,materials science, biomaterials
Near infrared triggered cascade reactions for photothermal/chemodynamic synergistic therapy

Peijing An,Songjinma Yin,Yule Qiang,Fuyi Shui,Qiao Zhang,Congbiao Zhao,Haipin Zhou,Fenyu Yu,Fu-Yi Shui

DOI: https://doi.org/10.1039/d3nj02243a

IF: 3.3

2023-08-09

New Journal of Chemistry

Abstract:In recent years, solving the problem of insufficient H2O2 level at tumor site has become the key of chemodynamic therapy (CDT). GOx is an efficient H2O2 producing enzyme, but the anoxic environment of the tumor cannot meet its continuous oxygen consumption, thus limiting the H2O2 production. In this work, perfluoropentane (PFP) was used as oxygen carrier to deliver oxygen to the tumor site and achieve photothermal intelligent release, thus achieving photolock-free H2O2 generation. First, mesoporous copper sulfide nanoparticles (denoted as HMC) were prepared, surface-modified with GOx (denoted as HMCG), and then loaded with PFP and oxygen (PO@HMCG) to achieve photolocation-induced photothermal and chemokinetic treatment.Among them, HMC has photothermal conversion performance. Under near infrared light, it releases Cu2+/Cu+, realizing photothermal enhancement of ROS generation and GSH consumption, thus enhancing intracellular oxidative stress. At the same time, when the local temperature rises above the boiling point of PFP, the transformation of PFP from liquid to gaseous state is realized, and oxygen is released to provide raw material for the catalytic process of GOx and activate the synthesis of H2O2.In vitro and in vivo experiments have shown that PO@HMCG can achieve the combination of photothermal and chemodynamic treatment of photounlocking, not only achieve excellent tumor inhibition effect, but also avoid the damage to normal tissue.

chemistry, multidisciplinary
Stochastic Discount Factor Models and the Equity Premium Puzzle

Christopher Otrok,B. Ravikumar,C. Whiteman

2001-11-01

Abstract:One view of the equity premium puzzle is that in the standard asset-pricing model with time-separable preferences, the volatility of the stochastic discount factor, for plausible values of risk aversion, is too low to be consistent with consumption and asset return data. We adopt this characterization of the puzzle, due to Hansen and Jagannathan (1991), and establish two results: (i) resolutions of the puzzle based on complete frictionless markets and non-separabilities in preferences are very sensitive to small changes in the consumption data, and (ii) models with frictions avoid this sensitivity problem. Using quarterly data from 1947-97, we calibrate a state non-separable model and a time non-separable model to satisfy the Hansen-Jagannathan volatility bound and show that the two resolutions are not robust. We support our argument via a bootstrap experiment where the models almost always violate the bound. These violations are primarily due to the fact that small changes in consumption growth moments imply changes in the mean of the stochastic discount factor, which render the volatility of the stochastic discount factor to be too low relative to the bound. Asset-pricing models with frictions, however, are much more successful in the bootstrap experiment relative to the case without frictions.
Light Amplified Oxidative Stress in Tumor Microenvironment by Carbonized Hemin Nanoparticles for Boosting Photodynamic Anticancer Therapy

Liyun Lin,Wen Pang,Xinyan Jiang,Shihui Ding,Xunbin Wei,Bobo Gu

DOI: https://doi.org/10.1038/s41377-021-00704-5

2022-01-01

Abstract:Photodynamic therapy (PDT), which utilizes light excite photosensitizers (PSs) to generate reactive oxygen species (ROS) and consequently ablate cancer cells or diseased tissue, has attracted a great deal of attention in the last decades due to its unique advantages. However, the advancement of PDT is restricted by the inherent characteristics of PS and tumor microenvironment (TME). It is urgent to explore high-performance PSs with TME regulation capability and subsequently improve the therapeutic outcomes. Herein, we reported a newly engineered PS of polymer encapsulated carbonized hemin nanoparticles (P-CHNPs) via a facile synthesis procedure for boosting photodynamic anticancer therapy. Solvothermal treatment of hemin enabled the synthesized P-CHNPs to enhance oxidative stress in TME, which could be further amplified under light irradiation. Excellent in vitro and in vivo PDT effects were achieved due to the improved ROS (hydroxyl radicals and singlet oxygen) generation efficiency, hypoxia relief, and glutathione depletion. Moreover, the superior in vitro and in vivo biocompatibility and boosted PDT effect make the P-CHNPs a potential therapeutic agent for future translational research.
A tumor pH-responsive autocatalytic nanoreactor as a H2O2 and O2 self-supplying depot for enhanced ROS-based chemo/photodynamic therapy

Furong Liu,Tao He,Songlin Gong,Meiling Shen,Shuang Ma,Xianzhou Huang,Lu Li,Li Wang,Qinjie Wu,Changyang Gong

DOI: https://doi.org/10.1016/j.actbio.2022.10.002

IF: 10.633

2022-12-01

Acta Biomaterialia

Abstract:Combining the internal force-driven chemodynamic therapy (CDT) and the external energy-triggered photodynamic therapy (PDT) holds great promise to achieve an advanced anticancer effect based on reactive oxygen species (ROS). However, the insufficient oxy-substrates supply in tumor microenvironment, like hydrogen peroxide (H2O2) and oxygen (O2), is the Achilles heel that greatly restricts the efficacy of this ROS-based treatment. Herein, the construction of a copper peroxide-based tumor pH-responsive autocatalytic nanoreactor (CESAR), via an albumin-mediated biomimetic mineralization strategy is described. The decoration of human serum albumin endows the nanoreactor good hydrophilicity and biocompatibility, which is highly desired for the metal-based materials. Upon exposure to acidic tumor microenvironment, CESAR presents a pH-triggered disintegration with Cu2+, H2O2 and O2 generated instantly. The generated H2O2 complements the hyperoxide deficiency and initiates a localized Fenton-like reaction with the assistance of Cu2+ for highly toxic hydroxyl radicals (•OH) production for improving CDT. The evolved O2 gas enables hypoxia relief for enhanced Ce6-mediated PDT. This H2O2/O2 self-supplying strategy significantly amplifies the tumor oxidative damage and gains an optimal treatment outcome, which offers a new paradigm for optimizing the tumor therapeutic options limited by oxide or hyperoxide deficiency, not only for CDT/PDT, but also other oxy-substrates involved strategies. STATEMENT OF SIGNIFICANCE: The shortage of oxy-substrates in the tumor microenvironment remains a great challenge for ROS-based cancer therapy. Herein, we introduce human serum albumin as a scaffold to stabilize copper peroxide nanomaterials for constant production of H2O2 and O2 to enhance chemodynamic/photodynamic therapy. The tumor pH-triggered H2O2/O2 production and Cu2+ release are confirmed, assuring the strategy of a highly precise, effective way to destroy tumor without any side effects. This work lends new and exciting insights into the engineering design of autocatalytic oxy-substrates self-supply nanoreactor for overcoming the bottlenecks, like the oxy-substrates deficiency of CDT/PDT and the poor stability of metal peroxides, to achieve highly effective chemodynamic/photodynamic therapy.

engineering, biomedical,materials science, biomaterials
Polymeric Nanoparticles with ROS‐Responsive Prodrug and Platinum Nanozyme for Enhanced Chemophotodynamic Therapy of Colon Cancer

Ying Hao,Yuwen Chen,Xinlong He,Yongyang Yu,Ruxia Han,Yang Li,Chengli Yang,Danrong Hu,Zhiyong Qian

DOI: https://doi.org/10.1002/advs.202001853

IF: 15.1

2020-09-06

Advanced Science

Abstract:The combination of chemotherapy and photodynamic therapy (PDT) has promising potential in the synergistic treatment of cancer. However, chemotherapy and photodynamic synergistic therapy are impeded by uncontrolled chemotherapeutics release behavior, targeting deficiencies, and hypoxia‐associated poor PDT efficacy in solid tumors. Here, a platinum nanozyme (PtNP) loaded reactive oxygen species (ROS)‐responsive prodrug nanoparticle (CPT‐TK‐HPPH/Pt NP) is created to overcome these limitations. The ROS‐responsive prodrug consists of a thioketal bond linked with camptothecin (CPT) and photosensitizer‐2‐(1‐hexyloxyethyl)‐2‐devinyl pyropheophorbide‐a (HPPH). The PtNP in CPT‐TK‐HPPH/Pt NP can efficiently catalyze the decomposition of hydrogen peroxide (H2O2) into oxygen to relieve hypoxia. The production of oxygen can satisfy the consumption of HPPH under 660 nm laser irradiation to attain the on‐demand release of CPT and ensure enhanced photodynamic therapy. As a tumor diagnosis agent, the results of photoacoustic imaging and fluorescence imaging for CPT‐TK‐HPPH/Pt NP exhibit desirable long circulation and enhanced in vivo targeting. CPT‐TK‐HPPH/Pt NPs effectively inhibit tumor proliferation and growth in vitro and in vivo. CPT‐TK‐HPPH/Pt NP, with its excellent ROS‐responsive drug release behavior and enhanced PDT efficiency can serve as a new cancer theranostic agent, and will further promote the research of chemophotodynamic synergistic cancer therapy.

materials science, multidisciplinary,nanoscience & nanotechnology,chemistry
Tumor Microenvironment-Responsive Theranostic Nanoplatform for Guided Molecular Dynamic/Photodynamic Synergistic Therapy

Dong-Yang Zhang,Fanglin Huang,Yan Ma,Guangzhong Liang,Zhuo Peng,Shixia Guan,Junqiu Zhai

DOI: https://doi.org/10.1021/acsami.1c03277

2021-04-08

Abstract:The integration of reactive oxygen species (ROS)-involved molecular dynamic therapy (MDT) and photodynamic therapy (PDT) holds great promise for enhanced anticancer effects. Herein, we report a biodegradable tumor microenvironment-responsive nanoplatform composed of sinoporphyrin sodium (SPS) photosensitizer-loaded zinc peroxide nanoparticles (SPS@ZnO2 NPs), which can enhance the action of ROS through the production of hydrogen peroxide (H2O2) and singlet oxygen (1O2) for MDT and PDT, respectively, and the depletion of glutathione (GSH). Under these conditions, SPS@ZnO2 NPs show excellent MDT/PDT synergistic therapeutic effects. We demonstrate that the SPS@ZnO2 NPs quickly degrade to H2O2 and endogenous Zn2+ in an acidic tumor environment and produce toxic 1O2 with 630 nm laser irradiation both in vitro and in vivo. Anticancer mechanistic studies show that excessive production of ROS damages lysosomes and mitochondria and induces cellular apoptosis. We show that SPS@ZnO2 NPs increase the uptake and penetration depth of photosensitizers in cells. In addition, the fluorescence of SPS is a powerful diagnostic tool for the treatment of tumors. The depletion of intracellular GSH through H2O2 production and the release of cathepsin B enhance the effectiveness of PDT. This theranostic nanoplatform provides a new avenue for tumor microenvironment-responsive and ROS-involved therapeutic strategies with synergistic enhancement of antitumor activity.

materials science, multidisciplinary,nanoscience & nanotechnology
Dual-responsive nanoplatform for integrated cancer diagnosis and therapy: Unleashing the power of tumor microenvironment

Rui Ma,Peng Zhang,Xiuying Chen,Mengdi Zhang,Qinghe Han,Qinghai Yuan

DOI: https://doi.org/10.3389/fchem.2024.1475131

IF: 5.5

2024-10-09

Frontiers in Chemistry

Abstract:Chemodynamic therapy (CDT), designed to trigger a tumor-specific hydrogen peroxide (H 2 O 2 ) reaction generating highly toxic hydroxyl radicals (·OH), has been investigated for cancer treatment. Unfortunately, the limited Fenton or Fenton-like reaction rate and the significant impact of excessive reducing glutathione (GSH) in the tumor microenvironment (TME) have severely compromised the effectiveness of CDT. To address this issue, we designed a dual-responsive nanoplatform utilizing a metal-polyphenol network (MPN) -coated multi-caged IrO x for efficient anti-tumor therapy in response to the acidic TME and intracellular excess of GSH, in which MPN composed of Fe 3+ and tannic acid (TA). Initially, the acidic TME and intracellular excess of GSH lead to the degradation of the MPN shell, resulting in the release of Fe 3+ and exposure of the IrO x core, facilitating the efficient dual-pathway CDT. Subsequently, the nanoplatform can mitigate the attenuation of CDT by consuming the excessive GSH within the tumor. Finally, the multi-caged structure of IrO x is advantageous for effectively implementing photothermal therapy (PTT) in coordination with CDT, further enhancing the therapeutic efficacy of tumors. Moreover, the outstanding Computed Tomography (CT) and Magnetic Resonance Imaging (MRI) (T 1 /T 2 ) multimodal imaging capabilities of IrO x @MPN enable early diagnosis and timely treatment. This work provides a typical example of the construction of a novel multifunctional platform for dual-responsive treatment of tumors.

chemistry, multidisciplinary
All-in-One HN@Cu-MOF nanoparticle with Enhanced Reactive Oxygen Species Generation and GSH Depletion for Effective Tumor Treatment

Shuhui Chen,Yu Yan,Yixuan Chen,Kaili Wang,Yawen Zhang,Xinlong Wang,Xurui Li,Jian Wen,Yue Yuan

DOI: https://doi.org/10.1039/d3tb02433d

IF: 7.571

2023-11-22

Journal of Materials Chemistry B

Abstract:Non-invasive cancer therapies, especially those based on reactive oxygen species, including photodynamic therapy (PDT), have aroused great interest. As an emerging photodynamic nanocarrier, metal-organic framework (MOF) based on porphyrin that can release reactive oxygen species (ROS) to destructive cancer cells. However, due to the inefficient production of ROS by photosensitizers and the over-expression of glutathione (GSH) in tumor microenvironment (TME), the therapeutic effect is not satisfactory. Therefore, we developed a multi-functional nanoparticle HN@Cu-MOF to enhance the efficacy of PDT. We combined chemical dynamic therapy (CDT) and Nitric oxide (NO) therapy by initiating the sensitization to PDT and cell apoptosis in the treatment of tumors. The Cu2+-doped MOF reacted with GSH to form Cu+, exhibited strong CDT ability to generate hydroxyl radicals (·OH). Cu-MOF was coated with the HN, which is hyaluronicacid (HA) modified by a nitric oxide donor. HN can target tumor cells that over-expressed CD44 receptor and consume GSH in the cells to release NO. Both cell experiments and in vivo experiments showed an excellent tumor inhibitory effect under the treatment. Overall, the HN@Cu-MOF nanoparticle integrated NO gas therapy and CDT with PDT, leading to significant enhancing the GSH consumption and a remarkable elevation of ROS production.

materials science, biomaterials
All-in-One Theranostic Nanoagent with Enhanced Reactive Oxygen Species Generation and Modulating Tumor Microenvironment Ability for Effective Tumor Eradication.

Yang Liu,Wenyao Zhen,Longhai Jin,Songtao Zhang,Guoying Sun,Tianqi Zhang,Xia Xu,Shuyan Song,Yinghui Wang,Jianhua Liu,Hongjie Zhang

DOI: https://doi.org/10.1021/acsnano.8b01893

IF: 17.1

2018-01-01

ACS Nano

Abstract:Despite regulation of the reactive oxygen species (ROS) level is an intelligent strategy for cancer therapy, the therapeutic effects of ROS-mediated therapy (including photodynamic therapy (PDT) and chemodynamic therapy (CDT)) are limited by oxygen reliance, inherent flaws of traditional photosensitizers, and strict reaction conditions of effective Fenton reaction. Herein, we reported biocompatible copper ferrite nanospheres (CFNs) with enhanced ROS production under irradiation with a 650 nm laser through direct electron transfer and photoenhanced Fenton reaction and high photothermal conversion efficiency upon exposure to an 808 nm laser, exhibiting a considerable improved synergistic treatment effect. Importantly, by exploiting the properties of 02 generation and glutathione (GSH) depletion of CFNs, CFNs relieve the hypoxia and antioxidant capability of the tumor, achieving photoenhanced CDT and improved PDT. The high relativity of 468.06 mM(-1) s(-1) enables CFNs to act as an outstanding contrast agent for MRI in vitro and in vivo. These findings certify the potential of such "all in one" nanotheranostic agent integrated PDT, photoenhanced CDT, photothermal therapy (PTT), and MRI imaging capabilities along with modulating the tumor microenvironment function in theranostics of cancer.
Visual dual chemodynamic/photothermal therapeutic nanoplatform based on superoxide dismutase plus Prussian blue

Shan Lei,Jinxing Chen,Kun Zeng,Mozhen Wang,Xuewu Ge

DOI: https://doi.org/10.1007/s12274-019-2348-1

IF: 9.9

2019-03-06

Nano Research

Abstract:<div>Enzyme-based anticancer therapy is more attractive for the less side effect than conventional chemotherapy. However, the poor stability and low membrane permeability of enzymes during the intracellular delivery are constraints for its practical applications. In this work, we synthesized novel near-infrared (NIR)-responsive core–shell-structured Prussian blue@fibrous SiO2 (PBFS) nanoparticles as the carrier of superoxide dismutase (SOD) and a glutathione (GSH)-activated Fenton reagent (DiFe). The PBFS nanoparticles are further modified with a GSH-responsive cationic polymer (poly(2-(acryloyloxy)-N,N-dimethyl-N-(4-(((2-((2-(((4-methyl-2-oxo-2H-chromen-7-yl)carbamoyl)oxy)ethyl)disulfaneyl) ethoxy)carbonyl)amino)benzyl)ethan-1-aminium, PSS) containing disulfide bonds and fluorophores. After SOD and DiFe are loaded on the PBFS-PSS nanoparticles, dual chemodynamic/photothermal therapeutic nanoparticulate systems (PBFS-PSS/DiFe/SOD) are obtained. In vitro experiments show that PBFS-PSS/DiFe/SOD nanoparticles have good biocompatibility and can be tracked under fluorescence microscope during the intracellular delivery process in MCF-7 tumor cells due to the GSH-activated release of fluorophores. They also exhibit high efficiency in NIR photothermal conversion and GSH-activated Fenton reaction in tumor cells, thus achieving high-efficient killing effect of tumor cells based on the combination of photothermal and chemodynamic therapeutic performance (PTT and CDT). This work offers a novel pathway to construct a visual multifunctional nanomedicine platform for future cancer therapy.</div>

materials science, multidisciplinary,chemistry, physical,physics, applied,nanoscience & nanotechnology
Copper-doped MOF-based nanocomposite for GSH depleted chemo/photothermal/chemodynamic combination therapy

Lei Wang,Yatao Xu,Chao Liu,Weili Si,Wenjun Wang,Yewei Zhang,Liping Zhong,Xiaochen Dong,Yongxiang Zhao

DOI: https://doi.org/10.1016/j.cej.2022.135567

IF: 15.1

2022-06-01

Chemical Engineering Journal

Abstract:Chemodynamic therapy (CDT) can kill cancer cells by generating toxic agents within tumors through Fenton-/Fenton-like reaction, exhibiting high tumor specificity and low systemic toxicity. However, the therapeutic effect of CDT is usually limited by the overexpressed glutathione (GSH) and low catalytic efficiency in the tumor microenvironment. To deplete GSH and achieve chemo/photothermal/chemodynamic combination therapy, Cu2+, the photothermal material polydopamine (PDA), and chemotherapeutic agent DOX were used to construct a copper-doped MOF-based nanocomposite (2+/, DCZP). The Cu2+ could be reduced to Cu+ by GSH to achieve GSH depletion and CDT activation. Under laser irradiation, the heat generated by DCZP could be used for photothermal therapy and promote the Fenton-like reaction with the released DOX to achieve combination therapy. Extracellular experiments demonstrated that more than 50% of GSH could be consumed and the generated heat upon laser irradiation could promote •OH production. In vitro experiments showed that the DCZP combined therapy resulted in 49.4% of late cell apoptosis. More importantly, under the combination therapy of DCZP, the tumors of mice were almost ablated and the expression of tumor growth factors also could be suppressed. The work provided a promising strategy by constructing a GSH depletion and combination therapy nanocomposite for safe and efficient cancer therapy.

Variation in growth and diterpene lactones among field-cultivated Andrographis paniculata

H 2 O 2 Self-Supplying and GSH-Depleting Nanoplatform for Chemodynamic Therapy Synergetic Photothermal/Chemotherapy

Photoperiodic induced melatonin regulates immunity and expression pattern of melatonin receptor MT1 in spleen and bone marrow mononuclear cells of male golden hamster.

Tumor-targeting polymer nanohybrids with amplified ROS generation for combined photodynamic and chemodynamic therapy

Open-Source and Reduced-Expenditure Nanosystem with ROS Self-Amplification and Glutathione Depletion for Simultaneous Augmented Chemodynamic/Photodynamic Therapy

Glutathione/pH-responsive copper-based nanoplatform for amplified chemodynamic therapy through synergistic cycling regeneration of reactive oxygen species and dual glutathione depletion

Self-Supply Oxygen ROS Reactor via Fenton-like Reaction and Modulating Glutathione for Amplified Cancer Therapy Effect

Hydrogen peroxide self-sufficient and glutathione-depleted nanoplatform for boosting chemodynamic therapy synergetic phototherapy

A hollow Co3-xCuxS4 with glutathione depleting and photothermal properties for synergistic dual-enhanced chemodynamic/photothermal cancer therapy

A Photo‐Activated Continuous Reactive Oxygen Species Nanoamplifier for Dual‐Dynamic Cascade Cancer Therapy

Near infrared triggered cascade reactions for photothermal/chemodynamic synergistic therapy

Stochastic Discount Factor Models and the Equity Premium Puzzle

Light Amplified Oxidative Stress in Tumor Microenvironment by Carbonized Hemin Nanoparticles for Boosting Photodynamic Anticancer Therapy

A tumor pH-responsive autocatalytic nanoreactor as a H2O2 and O2 self-supplying depot for enhanced ROS-based chemo/photodynamic therapy

Polymeric Nanoparticles with ROS‐Responsive Prodrug and Platinum Nanozyme for Enhanced Chemophotodynamic Therapy of Colon Cancer

Tumor Microenvironment-Responsive Theranostic Nanoplatform for Guided Molecular Dynamic/Photodynamic Synergistic Therapy

Dual-responsive nanoplatform for integrated cancer diagnosis and therapy: Unleashing the power of tumor microenvironment

All-in-One HN@Cu-MOF nanoparticle with Enhanced Reactive Oxygen Species Generation and GSH Depletion for Effective Tumor Treatment

All-in-One Theranostic Nanoagent with Enhanced Reactive Oxygen Species Generation and Modulating Tumor Microenvironment Ability for Effective Tumor Eradication.

Visual dual chemodynamic/photothermal therapeutic nanoplatform based on superoxide dismutase plus Prussian blue

Copper-doped MOF-based nanocomposite for GSH depleted chemo/photothermal/chemodynamic combination therapy